Does low magnesium contribute to vasoconstriction and higher cardiovascular risk?

Magnesium is a vital regulator of vascular health, maintaining endothelial integrity and vascular smooth muscle cell (VSMC) tone. Suboptimal magnesium levels compromise these physiological pathways, leading to arterial constriction and increased cardiovascular risk.

Mechanistic explanations

• Calcium antagonism: Magnesium acts as a natural calcium channel antagonist in VSMCs. Low levels permit excessive intracellular calcium influx, triggering contractile signaling and direct vasoconstriction.
• Endothelial dysfunction: Magnesium deficiency reduces the synthesis and bioavailability of nitric oxide (NO) and prostacyclin. This suppresses smooth muscle relaxation pathways while increasing oxidative stress and endothelin-1, shifting the vascular balance toward contraction.
• Vascular calcification: Low magnesium promotes calcium deposition in VSMCs by decreasing the activation of the calcium-sensing receptor (CaSR) and reducing the inhibition of mineral deposition.

Clinical evidence

• Cardiovascular risk: Large prospective cohorts link low serum magnesium and dietary intake to elevated risks of heart failure, stroke, and fatal ischemic heart disease. Notably, observational data show that every 50 mg/day increase in dietary magnesium is associated with a 22% lower coronary artery calcification (CAC) score.
• Supplementation limitations: While clinical trials show magnesium supplementation improves endothelial function (measured via flow-mediated dilation) in depleted individuals, randomized controlled trials (such as the 12-month MAGiCAL-CKD trial) demonstrate that oral supplementation does not slow or reverse established vascular calcification or arterial stiffness.

Bottom line

• Low magnesium levels drive vasoconstriction and vascular calcification through impaired calcium antagonism and reduced nitric oxide bioavailability, significantly increasing long-term cardiovascular risk. However, while correcting a deficiency supports acute vascular function, clinical evidence indicates supplementation does not reverse established, advanced arterial calcification.